Communiqués Thermo Fisher Scientific Inc.

Actions

TMO

US8835561023

Equipement et technologie médicale avancés

Marché Fermé - Nyse Autres places de cotation 22:00:02 13/06/2025			Varia. 5j.	Varia. 1 janv.
402,76 ^USD	-2,93%		+0,21%	-22,58%

13/06	Transactions du jour - Fusions et acquisitions	RE
13/06	Transactions du jour - Fusions et acquisitions	RE

Communiqués

Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research	02/06	BU
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs	30/05	AQ
Thermo Fisher Scientific Introduces Next Generation TruNarc Handheld Narcotics Analyzers to Support Public Safety	23/05	AQ
Thermo Fisher Scientific Declares Quarterly Dividend	21/05	BU
Proteomics Market worth $60.5 billion by 2029 driven by Rising Tech Innovations	14/05	AQ
Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13	06/05	BU
Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics	29/04	AQ
Thermo Fisher Scientific Invests to Enhance U.S. Innovation and Support Customers’ Manufacturing	24/04	BU
Thermo Fisher: Q1 Earnings Snapshot	23/04	AQ
Thermo Fisher Scientific Reports First Quarter 2025 Results	23/04	BU
Phenom Ranked #1 for Extended CRM Emphasis Use Case in the 2025 Gartner Critical Capabilities for Talent Acquisition (Recruiting) Suites Report	15/04	AQ
AGC Biologics Strengthens Single-Use Technology Network and Adds 5,000 L Vessels from Thermo Scientific to New Yokohama, Japan Facility	08/04	AQ
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 23, 2025	01/04	BU
Thermo Fisher Scientific Introduces the Vulcan Automated Lab to Transform Semiconductor Analysis	19/03	AQ
Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis	18/03	BU
Trian Comments on Solventum’s Sale of its Purification & Filtration Business	26/02	AQ
Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B	25/02	PR
Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business	25/02	BU
Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025	24/02	BU
Thermo Fisher Scientific Increases Quarterly Dividend	19/02	BU
Thermo Fisher Scientific Elects New Director to Board	19/02	BU
Correction: Too low direct sales reported in year-end report "Devyser Diagnostics AB publishes year-end report for January to December 2024"	13/02	AQ
Thermo Fisher Scientific s New Spatial Imaging System Enables Researchers to Generate High-quality Data, Making it Easier to Enter the Field of Spatial Tissue Proteomics	13/02	AQ
Devyser Diagnostics AB publishes year-end report for January to December 2024	13/02	AQ
Energize Supports Four Global Healthcare Companies Collaborating on a Multi-buyer PPA for a Long-term Supply of Renewable Electricity	07/02	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Thermo Fisher ouvre le bal dans la biotech en grande pompe

Le 25 juillet 2024 à 14:25